Europe Orthopedic Navigation Systems Market - Global Industry Insights, Trends and Growth Opportunity Analysis to 2030

 Europe Orthopedic Navigation Systems Industry Overview

The Europe Orthopedic Navigation Systems Market size is expected to reach USD 2,504.4 million by 2030, according to a new report published by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.8% from 2023 to 2030. The rising number of target diseases especially in the geriatric population is responsible for the rapid growth of the market. According to the Executive Agency for Health and Consumers, one in ten people in the geriatric population in Europe is suffering from osteoarthritis.

Minimal invasion and low post-operative complications associated with computer-assisted surgery are anticipated to drive regional market growth over the forecast period. Moreover, the introduction of technologically advanced products is expected to induce demand for orthopedic navigation systems. For instance, Orthokey Italia developed a new version of KiRA system integrating it with the iPad to aid in the study of the kinematics of a patient’s knee joint. Moreover, favorable reimbursement policies associated with orthopedic navigation systems are anticipated to further propel the demand over the forecast period.

During the outbreak of COVID-19, non-emergency procedures were canceled, which adversely impacted the market, as restrictions resulted in delays for a number of procedures. Approximately 10 million individuals in the U.K. are waiting for surgical procedures, increasing from 4 million before the pandemic. Currently, most nations have elevated restrictions on elective surgery. As a result of the recommencement of surgical procedures at full force, the market is anticipated to gather pace in the forthcoming years.

Europe Orthopedic Navigation Systems Market Segmentation

Grand View Research has segmented the Europe orthopedic navigation systems market based on application, end-use, and country:

Based on the Application Insights, the market is segmented into Knee, Hip and Spine.

  • The knee navigation system dominated the Europe orthopedic navigation systems market in terms of revenue with a revenue share of 45.0% in 2022. The increasing usage of computer-assisted surgery for knee replacement procedures and wide applications of the surgical navigation system in knee replacement surgeries are the key factors contributing to the growth of this segment.
  • Hip surgery-based navigation systems are expected to witness rapid growth in usage rates due to the increasing volume of hip replacement procedures and incidences of hip fracture, osteoarthritis, and rheumatoid arthritis.

Based on the End-Use Insights, the market is segmented into Hospitals and Ambulatory Surgical Centers.

  • The hospitals segment held the largest revenue share in 2023. Hospitals provide better treatment options relating to orthopedic procedures as compared to other treatment facilities.
  • The Ambulatory Surgical Centers (ASCs) segment is projected to show significant CAGR in the forthcoming years. The reduced waiting period, shorter stay duration, and personalized care are some of the key benefits offered by ASCs, which are expected to attract more patients in the forthcoming years.

Europe Orthopedic Navigation Systems Regional Outlook

  • K.
  • Germany
  • France
  • Italy
  • Spain
  • Switzerland
  • Belgium
  • Austria
  • Netherlands

Key Companies Profile

The industry is competitive and manufacturers are engaged in rigorous R&D to develop cost-effective and efficient products for reconstructive joint replacement surgery. In addition, technological advancements and strategic alliances are expected to provide this market with a lucrative growth platform.

Some prominent players in the global Europe Orthopedic Navigation Systems market include

  • Braun Melsungen AG
  • Stryker
  • Medtronic
  • Brainlab AG
  • Johnson & Johnson Services, Inc. (DePuy Synthes)
  • Zimmer Biomet
  • MicroPort Medical
  • Orthokey Italia SRL.
  • Amplitude

Order a free sample PDF of the Europe Orthopedic Navigation Systems Market Intelligence Study, published by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

Spinal Implants & Devices Market Forecast Analysis by Manufacturer, Types, Applications and Regions 2023 – 2030

  Spinal Implants & Devices Industry Overview The global  Spinal Implants & Devices Market  size is expected to reach USD 19.0 billion by 2030 and is expected to expand at a CAGR of 5.2% in the forecast period, from 2023 to 2030, according to a new report by Grand View Research, Inc. The growing number of vehicular accidents is leading to increasing new cases of spinal cord injuries (SCIs). Other causes of SCIs include falls, violence, acts of violence, sports and recreation injuries, and diseases. Vehicular or road accidents and falls account for the majority of SCI cases. Fall-induced SCI is common among people aged 65 years and above. Acts of violence such as gunshot wounds or knife wounds account for around 12% of SCI cases. Sports activities such as diving in shallow water and impact sports lead to nearly 10% of SCIs. Cancer, osteoporosis, arthritis, and inflammation of the spinal cord also cause SCI. Based on National Spinal Cord Injury Statistical Center da...
Read more

Latin America Pharmaceutical Contract Manufacturing & Research Services Market Overview, Cost Structure Analysis and Forecast to 2030

  Latin America Pharmaceutical Contract Manufacturing & Research Services Industry Overview The  Latin America Pharmaceutical Contract Manufacturing & Research Services Market  size is expected to reach USD 40.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 7.5% from 2022 to 2030. The low cost of drug registration in Latin American countries and the economic growth are the key factors contributing to progress in this region. Moreover, factors such as the growing demand for generics, rising investments in R&D, the growing geriatric population, and the increasing burden of chronic diseases are responsible for market growth. The outbreak of COVID-19 has boosted the market growth as companies have increased investments in R&D and manufacturing to develop vaccines and drugs against the COVID-19. During the coronavirus outburst, the supply chains of biopharmaceutical companies remained robust...
Read more